J&J says its Covid vaccine booster shot generated a promising immune response in early trials

J&J's booster dose generated virus-fighting antibodies "nine-fold higher" than those seen four weeks after the first dose, the company said.

from Health and Science https://ift.tt/3Be2QY3
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH